Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
29,000
+50 (0.17%)
Apr 29, 2026, 3:30 PM KST
10.48%
Market Cap 170.23B
Revenue (ttm) 208.61B
Net Income (ttm) 27.64B
Shares Out 5.88M
EPS (ttm) n/a
PE Ratio 6.16
Forward PE 5.17
Dividend 900.00 (3.11%)
Ex-Dividend Date Dec 29, 2025
Volume 14,910
Average Volume 10,388
Open 28,950
Previous Close 28,950
Day's Range 28,750 - 29,050
52-Week Range 26,000 - 33,950
Beta 0.22
RSI 49.09
Earnings Date May 15, 2026

About Daihan Pharmaceutical

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2025, Daihan Pharmaceutical's revenue was 208.61 billion, an increase of 2.16% compared to the previous year's 204.19 billion. Earnings were 27.64 billion, a decrease of -18.11%.

Financial Statements

News

There is no news available yet.